OLUMIANT

Identification of Olumiant

No description

Google image searchProduct monograph

Active ingredient

baricitinib, 4 MG

DIN: 02544768

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: ELI LILLY CANADA INC

Date: 09-APR-2024

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AF — Janus-associated kinase (JAK) inhibitors (ATC, ATC/DDD)
• L04AF02 — BARICITINIB (ATC/DDD)

External Links for Olumiant

Search on Google

• Olumiant side effects
• Olumiant dosage
• baricitinib side effects
• baricitinib dosage

Eli Lilly Canada Inc

Go to Eli Lilly website to see drug product details. Sometimes you can find olumiant photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.